These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 21908877)
21. IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation. Psachoulia K; Chamberlain KA; Heo D; Davis SE; Paskus JD; Nanescu SE; Dupree JL; Wynn TA; Huang JK Brain; 2016 Dec; 139(Pt 12):3121-3136. PubMed ID: 27797811 [TBL] [Abstract][Full Text] [Related]
22. Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis. Seyedsadr MS; Weinmann O; Amorim A; Ineichen BV; Egger M; Mirnajafi-Zadeh J; Becher B; Javan M; Schwab ME Neurobiol Dis; 2019 Apr; 124():189-201. PubMed ID: 30468865 [TBL] [Abstract][Full Text] [Related]
23. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952 [TBL] [Abstract][Full Text] [Related]
24. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects. Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441 [TBL] [Abstract][Full Text] [Related]
25. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nikić I; Merkler D; Sorbara C; Brinkoetter M; Kreutzfeldt M; Bareyre FM; Brück W; Bishop D; Misgeld T; Kerschensteiner M Nat Med; 2011 Apr; 17(4):495-9. PubMed ID: 21441916 [TBL] [Abstract][Full Text] [Related]
26. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis. Raine CS; Moore GR; Hintzen R; Traugott U Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499 [TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111 [TBL] [Abstract][Full Text] [Related]
28. Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis. Dupree JL; Polak PE; Hensley K; Pelligrino D; Feinstein DL J Neurochem; 2015 Jul; 134(2):302-14. PubMed ID: 25846048 [TBL] [Abstract][Full Text] [Related]
29. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811 [TBL] [Abstract][Full Text] [Related]
30. Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination. Pennati A; Nylen EA; Duncan ID; Galipeau J J Neurosci; 2020 Jun; 40(26):5105-5115. PubMed ID: 32430295 [TBL] [Abstract][Full Text] [Related]
31. Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation. Rajendran R; Giraldo-Velásquez M; Stadelmann C; Berghoff M Brain Pathol; 2018 Mar; 28(2):212-224. PubMed ID: 28117910 [TBL] [Abstract][Full Text] [Related]
32. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715 [TBL] [Abstract][Full Text] [Related]
33. Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin. Keough MB; Jensen SK; Yong VW J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867716 [TBL] [Abstract][Full Text] [Related]
34. Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Weinger JG; Davies P; Acker CM; Brosnan CF; Tsiperson V; Bayewitz A; Shafit-Zagardo B J Neuropathol Exp Neurol; 2012 May; 71(5):422-33. PubMed ID: 22487860 [TBL] [Abstract][Full Text] [Related]
35. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis. Bullard DC; Hu X; Adams JE; Schoeb TR; Barnum SR Am J Pathol; 2007 Jun; 170(6):2001-8. PubMed ID: 17525267 [TBL] [Abstract][Full Text] [Related]
36. Genetic ablation of steroid receptor coactivator-3 promotes PPAR-beta-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis. Xiao Y; Xu J; Wang S; Mao C; Jin M; Ning G; Xu J; Zhang Y Glia; 2010 Jun; 58(8):932-42. PubMed ID: 20155818 [TBL] [Abstract][Full Text] [Related]
37. Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody. Bing SJ; Ha D; Ahn G; Cho J; Kim A; Park SK; Yu HS; Jee Y Clin Exp Immunol; 2015 Jun; 180(3):419-31. PubMed ID: 25619397 [TBL] [Abstract][Full Text] [Related]
38. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Johnson DA; Amirahmadi S; Ward C; Fabry Z; Johnson JA Toxicol Sci; 2010 Apr; 114(2):237-46. PubMed ID: 19910389 [TBL] [Abstract][Full Text] [Related]
39. The adenosine A Chen Y; Zhang ZX; Zheng LP; Wang L; Liu YF; Yin WY; Chen YY; Wang XS; Hou ST; Chen JF; Zheng RY Neurochem Int; 2019 Oct; 129():104490. PubMed ID: 31226280 [TBL] [Abstract][Full Text] [Related]
40. Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. Valentin-Torres A; Savarin C; Barnett J; Bergmann CC J Neuroinflammation; 2018 Apr; 15(1):121. PubMed ID: 29690885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]